The top five holdings of this healthcare fund are Johnson & Johnson (JNJ, 11.23% of assets); Pfizer, Inc. (PFE, 7.53 %); Merck & Company, Inc. (MRK, 6.21%), Gilead Sciences, Inc. (GILD, 5.46%); and Amgen Inc. (AMGN 4.65%). It rewarded shareholders with a 25% return in 2014.
Health Care Select Sector SPDR (XLV)
from The Chartist
Health Care Select Sector SPDR (XLV) seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index.
The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Dan Sullivan, The Chartist, www.thechartist.com, 900-942-4278, January 1, 2015